PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Current Features

Advertisement

Current Edition

Cell and Gene Therapy

Upcoming Events

BIO-Europe 2025 – 10.07.2025
Cell 2025 – 30.05.2025
Cell Leaders Awards – 30.05.2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
Light Cast – 17.07.2025
Current Features

Why Renting Product Inspection Systems Makes Strategic Sense for Pharma Manufacturers

Production lines don’t pause for procurement. When pharmaceutical manufacturers face a sudden spike in demand, new quality control requirements or equipment failure,...
Continue Reading →
Current Features

The Importance of Mass Spectrometry 

Mass spectrometry (MS) has long been a cornerstone analytical technique in the pharmaceutical and biopharmaceutical industries. Its ability to provide detailed molec...
Continue Reading →
Current Features

Plan, Lead, Deliver: A Framework for Regulatory Writing Success 

Q: Is your team simply writing a dossier, or are they following a clear strategy?A: The most effective teams do both, but strategy should come first. Preparing a sub...
Continue Reading →
Current Features

Navigating FDA and USP Regulatory Guidance with LAL Reagents for Bacterial Endotoxin Testing

Navigating the regulatory landscape of the Bacterial Endotoxin Test (BET) involves a thorough review of guidelines from regulatory agencies such as the FDA, USP, and...
Continue Reading →
Current Features

The Impact of Clinical Development Decisions on Time to Market and Development Risk in Oncology 

Key Findings• Every month a programme can accelerate to market adds an estimated $5–6M of net present value per billion dollars of peak year sales• We have identifie...
Continue Reading →
Current Features

Modelling the Bone Marrow Niche In Vitro: A Roadmap for Drug Development 

The bone marrow niche provides a tightly controlled setting where cellular interactions, biochemical signalling, and mechanical stimuli collectively shape the fate o...
Continue Reading →
Current Features

Challenging Targets in Antibody Discovery

Antibodies represent a rapidly growing therapeutic modality, demonstrating clinical success over a wide variety of diseases, including cancer, autoimmune disorders, ...
Continue Reading →
Current Features

Building the Foundation for Biopharma 4.0 Through Strategic Digital Transformation

What is Biopharma 4.0? Biopharma 4.0 refers to the next-generation modernisation approach to biopharmaceutical development, manufacturing, and quality. It integrates...
Continue Reading →
Current Features

TPDs: Developing the Next Generation of Oral Therapeutics

Targeted Protein Degraders (TPDs) are transforming the landscape of modern drug discovery and development, introducing a ground-breaking method for tackling diseases...
Continue Reading →
Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Drug Discovery 2025, ELRIG – 04.07.2025
Richter: Wed 23 October 2024, 09:03
Tosoh – 29.04.25
Eppendorf – 18.03.2025
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025

Company Profiles